Loading clinical trials...
Loading clinical trials...
Randomised, Double-blind, Placebo-controlled Study of APD421 (Amisulpride for IV Injection) as Treatment of Established Post-operative Nausea and Vomiting, in Patients Who Have Had no Prior Prophylaxis
Conditions
Interventions
APD421
Placebo
Locations
4
United States
Jackson Memorial Hospital
Miami, Florida, United States
Ohio State University
Columbus, Ohio, United States
CHU de Hautepierre
Strasbourg, France
Universität Heidelberg
Heidelberg, Germany
Start Date
September 1, 2015
Primary Completion Date
July 1, 2016
Completion Date
July 1, 2016
Last Updated
January 22, 2019
NCT07274215
NCT07271147
NCT06937684
NCT05804591
NCT06320613
NCT06865378
Lead Sponsor
Acacia Pharma Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions